Johnson & Johnson's stock price is at a critical turning point

Key PointsJohnson & Johnson has solid growth in core segments and reiterated its guidance for the year. The dividend is safe for 2024 and may include another increase this spring. Analysts have trimmed their targets and may cap gains for this stock in the year's first half. 5 stocks we like better than Johnson & JohnsonJohnson & Johnson NYSE: JNJ had a solid quarter in Q4 despite the impacts of the Kenvue spin-off and the deleveraging of COVID-19 sales. However, little has emerged to catalyze the bulls, alt ...